Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep674 | Pituitary and Neuroendocrinology | ECE2023

Tolvaptan in the management of severe hyponatremia associated with acute intermittent porphyria

Gomez Carlos Garcia , Armengod Laura , Abad Ainhoa , Garcia Izquierdo Belen , Guzman Sanz Jorge , Rubio Ramos Miguel , Capristan Diaz Vanesa , Diez Fernandez Natalia , Palacios Nuria

Background: Acute intermittent porphyria (AIP) is an inherited autosomal dominant disorder characterized by hepatic deficiency of hydroxymethylbilane synthase (HMBS)/porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Hyponatremia is one of the main presenting symptoms and it is thought to be related to an inadequate secretion of ADH (SIADH). Since AIP is an uncommon disease, there is little information about how AIP related hyponatremia responds ...

ea0081ep1153 | Thyroid | ECE2022

Role of plasmapheresis in the management of severe amiodarone-induced hyperthyroidism refractory to conventional medical treatment

Garcia Izquierdo Belen , Angulo Macarena Contreras , Grao Laura Armengod , Garcia Gomez Carlos , Garcia Garcia Alvaro , Maroto Azucena Losa , Cabrera Jose Luis Bueno , Serrano Miguel Juan Garcia- Oria , Donoso Encarnacio n , Iglesias Pedro

Introduction: Amiodarone is an antiarrhythmic drug whose high iodine content may influence thyroid function. The first line treatment of amiodarone-induced hyperthyroidism (AIH) is mainly medical. Plasmapheresis has been used in cases of antithyroid intolerance or refractory hyperthyroidism, although clinical experience is poor.Clinical case: We present a case of a patient with structural heart disease and severe AIH refractory to medical treatment who r...